Telesis Bio Inc. Annual Income Tax Expense (Benefit) in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Telesis Bio Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2023.
  • Telesis Bio Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $1K, a 92.9% decline year-over-year.
  • Telesis Bio Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $7K, a 74.1% decline year-over-year.
  • Telesis Bio Inc. annual Income Tax Expense (Benefit) for 2023 was $24K, unchanged from 2022.
  • Telesis Bio Inc. annual Income Tax Expense (Benefit) for 2022 was $24K, a 71.4% increase from 2021.
  • Telesis Bio Inc. annual Income Tax Expense (Benefit) for 2021 was $14K, a 180% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $24K $0 0% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-29
2022 $24K +$10K +71.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-29
2021 $14K +$9K +180% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
2020 $5K Jan 1, 2020 Dec 31, 2020 10-K 2022-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.